Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Turcot syndrome × Genitourinary × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 7 OTHER 2 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 48 Neoplasms 6 Urinary Bladder Neoplasms 4 Urinary Incontinence 3 Neoplasm Metastasis 3 Erectile Dysfunction 3 Non-Muscle Invasive Bladder Neoplasms 2 Lung Neoplasms 2 Breast Neoplasms 2 Weight Loss 1 Urogenital Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1 Recurrence 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Prostate cancer, familial 1 Prostate Cancer Prevention 1 Prostate Cancer Diagnosis 1 Patients With Prostate Cancer 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Obesity 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasms by Site 1 Motor Activity 1 Male Urogenital Diseases 1 Lung Diseases, Obstructive 1 Liver Neoplasms 1 Literacy 1

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04104893 2026-02-27

CHOMP

VA Office of Research and Development

Phase 2 Active not recruiting

Turcot syndrome, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡